Sign in

NCT07584343Completed

EMG of Gait Under Dual-Task in Parkinson Desease

Electromyographic Activity of the Tibialis Anterior and Medial Gastrocnemius in Parkinson's Disease During Forward and Backward Gait Under Dual-Tasking: A Descriptive Study

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

In this observational study embedded within a randomized controlled trial, the investigators aim to characterize the activation patterns of the tibialis anterior and medial gastrocnemius muscles in the more rigid leg of patients with Parkinson's disease when performing walking tasks under dual cognitive-task conditions, which are known to increase the risk of falls in this population. To this end, a control group without neurological disorders and with comparable sociodemographic characteristics will also be assessed. The study seeks to determine whether significant changes occur in forward and backward gait as a function of the dual-task condition.

Status (registry)
Completed
Study type
Observational
Enrollment
30 (actual)
First submitted
30 Apr 2026
Start date
15 Mar 2026
Primary completion date
30 Mar 2026
Lead sponsor
University of Cadiz
NCT number
NCT07584343

What you commit to

  • Study type: Observational
  • Participants enrolled: 30
  • From 15 Mar 2026 to the primary completion date, 30 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous treatment with deep brain stimulation.

Other illness

  • Presence of symptomatic musculoskeletal disorders affecting the lower limbs (LL) (relevant orthopedic surgery or leg length discrepancy \> 1 cm), or other neurological conditions (stroke, neuropathies, etc.) that independently affect gait.
  • Balance disorders due to other causes (vestibulopathy, severe orthostatic hypotension, etc.).
  • Decompensated systemic diseases (cardiac disease, COPD, uncontrolled diabetes mellitus, etc.).

Other

  • Uncorrected visual impairments that may affect gait performance.

Who the study is looking for

  • Ability to walk independently for at least 5 meters, both forward and backward, without the need for assistive devices or assistance from another person.
  • Diagnosis of idiopathic Parkinson's disease made by a neurologist at Hospital Virgen Macarena.
  • Hoehn and Yahr stage I-III.
  • Being in the "ON" phase of antiparkinsonian medication during the assessment (approximately one hour after intake, when the pharmacokinetic curve of levodopa reaches its peak).

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sevilla, España
Coordinator of this site? Confirm its status
SevilleSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.